April 15, 2019

Merz North America Regains Exclusive Distribution of Asclera Injection

April 16, 2019—Merz North America, Inc. announced that it has regained exclusive distribution of the Asclera (polidocanol) injection in the United States to all health care practitioners and phlebologists treating varicose veins in the lower extremities. AngioDynamics, Inc. is no longer an authorized distributor of Asclera.

All health care professionals will now be able to purchase Asclera directly from Merz. This includes specialties such as vascular surgery, interventional radiology, general surgery, plastic surgery, cardiology, vein clinics and vein centers, as well as hospitals. Prescribing information is available online at asclera.com.

The company advised that customers can purchase Asclera directly from Merz by calling 844-4MY-MERZ (844-469-6379). Merz will maintain Asclera part numbers and continue to honor current product list prices. Privately held Merz North America is headquartered in Raleigh, North Carolina. More information is available online at www.merzusa.com.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

April 15, 2019

Merz North America Regains Exclusive Distribution of Asclera Injection

Current Issue

Keep In Touch